5 Grants
2021
Proteasome inhibitors for the treatment of solid tumors
KISSELEV, ALEXEI
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA213223-05), $356,476USD, 2017-09-20 -- 2022-07-31
2020
Proteasome inhibitors for the treatment of solid tumors
KISSELEV, ALEXEI
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA213223-04), $356,318USD, 2017-09-20 -- 2022-07-31
2019
Proteasome inhibitors for the treatment of solid tumors
KISSELEV, ALEXEI
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA213223-03), $345,478USD, 09/20/2017 -- 07/31/2022
2018
Proteasome inhibitors for the treatment of solid tumors
KISSELEV, ALEXEI
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA213223-02), $356,014USD, 09/20/2017 -- 07/31/2022
2017
Novel Inhibitors of PSMB7 and PSMB10 for the Treatment of Multiple Myeloma
KISSELEV, ALEXEI and Pletnev, Alexandre
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R41CA221494-01A1), $296,354USD, 09/25/2017 -- 08/31/2018